ISPOR—The Professional Society for Health Economics and Outcomes Research

Learn more about the new ISPOR Strategic Plan 2030 that aims for a world where healthcare is accessible, effective, efficient, and affordable for all. ISPOR’s CEO Rob Abbott, President Dr Eberechukwu Onukwugha, and Past President Dr Brian O'Rourke discuss the bold, new plan. More at https://ow.ly/w4V750SUMHL. #HEOR #healthcare

Congratulations to C. Daniel Mullins, PhD, Executive Director of the PATIENTS Program and the Editor-in-Chief of ISPOR’s journal, Value in Health, on leading The University of Maryland School of Pharmacy in receiving nearly $10 million in federal funding to conduct research to improve health equity in Baltimore and beyond. The National Institutes of Health’s Common Fund Community Partnerships to Advance Science for Society (ComPASS) program awarded $9.4 million to the University’s PATIENTS Program to serve as a Health Equity Research Hub and?will fund community-led health equity research in Baltimore and surrounding communities. https://lnkd.in/eXZ2Z2sj ? #healthequity #research

Are you looking for talented HEOR professionals to fill your open positions? Post your job on the ISPOR HEOR Career Center before October 31 to receive 15% off. Use code TALENT1024 at checkout. https://ow.ly/z2KI50TCxXE #HEOR #Careers #Talent #Recruitment

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. Learn more: https://ow.ly/PRcZ50TzVTH #Drugpricenegotiation #IRA #CMS

Call for proposals!! This is an open call for ISPOR education proposals! This is your opportunity to contribute to the programming for ISPOR short courses and the ISPOR Education Center for 2025! Learning objectives for next year are focused on ISPOR’s 2024-2025 Top 10 HEOR Trends Report. Read the report here>> https://ow.ly/BswU50TtpHY. All submissions must be received by October 31. View the proposal guidelines here>> https://ow.ly/BH0050Tvy4S #HEOR Be sure to follow the HEOR Conferences LinkedIn page for updates on all ISPOR events>> https://lnkd.in/ga79mAav

ISPOR Europe 2024 plenaries and speakers announced. The conference is the leading European conference for health economics and outcomes research (HEOR) and is scheduled for 17-20 November in Barcelona, Spain with the theme, “Generating Evidence Toward Health and Well-Being.” #ISPOREurope Learn more: https://ow.ly/nrRU50TsKg7

HAPPENING NOW: The ISPOR HTA Roundtable - Middle East and Africa (MEA). 50 attendees from 28 different countries in the MEA region are meeting to discuss the development of economic evaluation guidelines and share case studies of working with international partners. Learn more here: https://ow.ly/WyH650Ts6Yl #healthtechnologyassessment #HTA #HEOR

Are you looking for talented HEOR professionals to fill your open positions? Post your job on the ISPOR HEOR Career Center before September 30 to receive 15% off. Use code TALENT0924 at checkout. #HEOR #Careers #Talent #Recruitment https://ow.ly/txth50TriKg

HEOR Headlines in the News: - “Interpreting the First Round of Maximum Fair Prices Negotiated By Medicare for Drugs” (Health Affairs) - “Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research?” (Clinical Leader) - “Mapping the Journey: Achieving Health System Sustainability” (Value & Outcomes Spotlight) Visit the HEOR News Desk for curated news stories from a variety of sources. Want these delivered directly to your inbox? Subscribe to the HEOR News Brief here>> https://ow.ly/CGxx50Tox6N #Medicare #HEOR #patienthealth Follow the HEOR Conferences LinkedIn page for updates on all ISPOR events>> https://lnkd.in/ga79mAav

ISPOR members responded to the European Medicines Agency’s reflection paper on the use of real-world data (RWD) in non-interventional studies to generate real-world evidence (RWE). ISPOR emphasized the importance and need for transparency in RWE studies, the importance of international harmonization of methods and data required, and clarification around study design/fit-for-purpose data and the amount of RWD coming from tokenization. See the full response here: https://ow.ly/59hA50ToFkG #RWE #realworldevidence #RWD #realworlddata